Thanks to advances in imaging and diagnostic technologies, clinicians can now detect many genetic disorders in the womb, opening the door to fetal therapies. This article will discuss how prenatal ...

Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.

When global risk rises, venture funding gets selective. Ecosystems and ventures that seek resilience rather than dependency ...

The company's platform integrates genomic sequencing, clinical data analytics, and AI-driven insights across oncology, cardiology, and neuropsychiatry. Tempus serves more than 50% of U.S. oncologists ...

The AI medical imaging market is projected to hit nearly $20 billion by 2033, growing at a 34.7% CAGR([1]) . Echocardiography alone is forecast to grow to $2.64 billion by 2030 as hospitals demand ...

Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare ...

In the Large-Cap Pharmaceuticals industry, Lilly, J&J, BAYRY and Sanofi are worth retaining as the industry shows some recovery.

Most talent strategies plan Boomer-to-Gen-X transitions. The actual handoff? Jones-to-Millennial. The generational map is ...

Crystal jellyfish have an eerie beauty: thanks to a natural protein, they emit a faint green glow. For decades, researchers ...

AGBT is also, increasingly, a showcase for instruments for spatial biology, a fast-growing field that involves pinpointing ...

The V8 is not dead. Far from it, actually, specifically for General Motors. New reports recently surfaced, shedding some details on Detroit’s next generation of thundering ochos. Announced last year, ...

Conference Call Begins at 4:30 p.m. Eastern Time TodayEMERYVILLE, Calif.--(BUSINESS WIRE)--$OABI #OABI--OmniAb, Inc. (NASDAQ: ...